How to Manage Low Platelet Count due to ITP or HCV Infection?

Trombopag 25mg/ 50 mg

The decrease in the number of platelets due to the effect of the hepatitis c virus remains a great problem among individuals. There can be many problems introduced due to the effect of the virus. There can be the rise of many other diseases that can accompany the infection. In the patients that possessed a chronic form of the virus, there is an decrease in the count of the platelets. Thrombopoietin refers to a growth factor formed in the liver, and now it binds itself to the receptors present in the platelets. When there is a decrease in the count of the platelets, it leads to a rise in the level of the growth factor and kick starts the rise in platelets formation by the megakaryocytes. This condition can become serious when the liver patients reach a chronic stage.

How can this situation be managed amid the HCV infection?

In some cases, the patients that possessed a lower platelet count could not receive the treatment properly due to the introduction of the growth factor. So when the platelet counts go to a minimum, there is a high risk for the patient under the therapy via antivirals. Hence the treatment is likely to be interrupted at this stage. Once the count of the platelets goes down, there is a high probability that the patient will develop a chance of thrombocytopenia.

The decrease in the platelet could be because it could be related to an advanced version of a disease. In such cases, even the retroviral therapies lead to a decrease in the number of platelets. Hence there are high chances for the ineffectiveness of the therapies in such situations. So the treatment might not be offered to them due to the rise in the risks. However, the solution for the problem has been brought in the form of Eltrombopag Olamine (trombopag) that has helped maintain the rise in the count of the platelets. Hence, receiving treatment effectively will benefit the patients for sure.

Analyzing the benefits of the new drugs

Trombopag 25 mg refers to a drug introduced to cure the low number of platelets observed in the patients due to the impact of the hepatitis c virus. These drugs help so that anti-retroviral therapies can also be offered to the patients along with the administration of these drugs. Hence it is a win situation since it can help the patients to receive better treatment and maintain the platelet count.

How to administer the drug?

Trombopag are taken in oral form. They are taken daily with water. However, the drug should be consumed only as per the doctor’s directions. It is better to consume the drug before consuming meals or milk products. The drug must be taken cautiously if the patient has experienced previous allergic reactions. It is better to take proper advice from the doctor before consuming the drug.

Trombopag 50 mg also serves the same purpose and can help in raising the count of the platelet for the patients that were unable to receive an effective form of treatment. The side effects of the drug were not serious, as per the observations from the doctor. Commonly seen were nausea and rashes in the skin along with a slow loss of hair.